Overcoming publication delays with DrugCard

Overcoming publication delays with DrugCard

In the ever-evolving pharmacovigilance landscape, swift access to the latest medical research is paramount. Addressing publication delays can be a game-changer, especially when ensuring patient safety and informed decision-making. While PubMed is a trusted resource for accessing medical journal articles, it isn’t always the quickest route. This article delves into how the automated pharmacovigilance platform DrugCard is redefining the industry by empowering professionals with early access to essential information while triumphing over publication delays.

The imperative of swift access: Why publication delays matter

Pharmacovigilance professionals constantly seek the latest data and research findings to monitor drug safety and assess potential risks. Regarding medical journals, PubMed has long been a primary source for accessing published articles. However, there’s often a time lag between when an article is printed on a journal’s website and when it appears on PubMed due to various reasons, including embargo periods, indexing processes, and administrative delays.

A real-world case: Uncovering the impact of publication delays

While analyzing the DrugCard platform’s monitoring system, we made an intriguing discovery. Our platform consistently identified articles from journals that are both included in and indexed by PubMed much faster than they were made available in the PubMed library. To illustrate this, let’s take an extreme example involving a case, ‘Ciprofloxacin-Induced Anaphylactic Reaction,’ published in the journal ‘Medicina (Kaunas).’ The DrugCard platform detected this article on the journal’s official website in early October, shortly after its publication. In contrast, our specialists only received it through PubMed’s monitoring results at the end of October. This striking time gap allowed our platform to alert its users several weeks earlier to this noteworthy case of anaphylactic reaction following the use of ciprofloxacin.

How DrugCard works

DrugCard, an automated pharmacovigilance platform, is changing the game. It continuously monitors local medical journals and some journals, including those indexed in PubMed. What sets it apart is its ability to find and provide access to information in articles on a journal’s official website even before these articles make their way into PubMed. DrugCard uses advanced algorithms to monitor and scrape data from medical journal websites in real time. This means that as soon as a new article is published on a journal’s website, DrugCard can detect it. When it discovers relevant information, DrugCard generates alerts and notifications for pharmacovigilance professionals. This ensures they can stay ahead of the curve and access critical data early. DrugCard covers many medical journals, so professionals can be confident they will get all essential research findings.

DrugCard: A solution to publication delays

By gaining access to information in articles before they appear on PubMed, pharmacovigilance professionals can make quicker decisions. They can also take necessary actions, particularly regarding drug safety concerns. Early access to critical information allows professionals to identify potential risks, adverse events, or emerging trends promptly. This, in turn, helps enhance patient safety. Professionals can streamline their research efforts by leveraging a tool like DrugCard, reducing the time spent searching for and waiting for articles to become available on PubMed. With access to various medical journals, DrugCard provides a comprehensive view of the latest research, helping professionals make well-informed decisions.

Conclusion: Bridging the gap and impacting healthcare

In the pharmacovigilance world, timely access to medical journal articles can be a game-changer. The striking time gap between DrugCard’s detection and PubMed’s inclusion underscores the importance of early access and the platform’s role in mitigating publication delays. Automated platforms like DrugCard empower professionals to stay ahead of the curve, improve patient safety, and efficiently access the latest research findings. By bridging the gap between journal publication and availability on PubMed, DrugCard is a valuable tool making waves in the field of pharmacovigilance. It’s a testament to how technology can significantly impact healthcare and patient well-being.

Looking for Expert Guidance?
Our team is on hand round the clock to guide you on how to enhance your literature screening or to offer consultation on your pharmacovigilance processes.
Unlock the Secrets of the Pharma Industry
Get Your Hands on Our Must-Read Business Case Today!
Follow us
Request a demo
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Have questuions?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DrugCard has roots in Ukraine. Support all Ukrainians in their fight against russian aggression